-
-
-
-
-
-
-
Lisata Therapeutics to be acquired by Kuva Labs for $4 per share
-
-
-
-
-
-
-
Lisata Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Lisata Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Lisata Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
-
-
-
-
1,158,087 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

